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Background: Results of previous reports on ischemic postconditioning in animals and humans were very
encouraging. Although ischemic postconditioning possessed a wide prospect of clinical application, debates on the
precise ischemic postconditioning algorithm to use in clinical settings were ongoing. In this regard,
pharmacological strategies were possible alternative methods. Accumulating data demonstrated that
pharmacological postconditioning with morphine conferred cardioprotection in animals. This trial aimed to evaluate
the effect of morphine-induced postconditioning on protection against myocardial ischemia/reperfusion injury in
patients undergoing corrections of Tetralogy of Fallot (TOF).
Methods: Eight-nine consecutive children scheduled for corrections of TOF were enrolled and randomly assigned
to either a postconditioning group (patients received a dose of morphine (0.1 mg/kg) injected via a cardioplegia
needle into the aortic root for direct and focused delivery to the heart within 1 minute starting at 3 min before
aorta cross-clamp removal, n=44) or a control group (the same protocol was performed as in the postconditioning
group except that patients received the same volume of saline instead, n=45). The peri-operative relevant data
were investigated and analyzed, and the cardiac troponin I (cTnI) was assayed preoperatively, and then 4 h, 8 h,
12 h, 24 h and 48 h after reperfusion.
Results: Morphine-induced postconditioning reduced postoperative peak cTnI release as compared to the control
group (0.57 ± 0.15 versus 0.75 ± 0.20 ng/mL, p<0.0001). Morphine-induced postconditioned patients had lower
peak inotropic score (5.7 ± 2.4 versus 8.4 ± 3.6, p<0.0001) and shorter duration of mechanical ventilation as well as
ICU stay (20.6 ± 6.8 versus 28.5 ± 8.3 hours, p<0.0001 and 40.4 ± 10.3 versus 57.8 ± 15.2 hours, p<0.0001,
respectively), while higher left ventricular ejection fraction as well as cardiac output (0.57±0.15 versus 0.51±0.13,
p=0.0467 and 1.39 ± 0.25 versus 1.24 ± 0.21 L/min, p=0.0029, respectively) as compared to the control group
during the first postoperative 24 hours.
Conclusions: Morphine-induced postconditioning may provide enhanced cardioprotection against ischemia/
reperfusion injury in children undergoing corrections of TOF.
Keywords: Pharmacological postconditioning, Morphine, Ischemia reperfusion injury, Pediatric cardiac surgery, TrialsBackground
Although the application of cardioplegia is an effective
strategy for cardio-protection, it does not completely
eradicate myocardial ischemia/reperfusion injury due to
cardiac arrest during cardiac surgery. It was well-
established that ischemic preconditioning, which involved
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reproduction in any medium, provided the orischemia, was explicitly cardioprotective strategy [1-5]. Un-
like preconditioning, ischemic postconditioning, which in-
volved brief episodes of ischemia/reperfusion during early
reperfusion, did not require initiation before the ischemic
event [1-8]. And hence, ischemic postconditioning was eas-
ily performed in all cardiac operations such as in those for
severe aortic valve insufficiency or aortic valve stenosis
where preconditioning often was difficult to be carried out
before operation due to possible heart arrest and distension
induced during repeated aortic clamping [1-8]. Results ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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encouraging in animals and humans [1-10].
Although ischemic postconditioning possessed a wide
prospect of clinical application, debates on the precise
ischemic postconditioning algorithm to use in clinical
settings were ongoing. In this regard, pharmacological
strategies [11,12], which would avoid some adverse con-
sequences associated with intermittent cross-clamping
(such as aortic injury, left ventricular distention, and malig-
nant arrhythmia), were possible alternative methods. Mor-
phine, a classic opioid drug, was particularly interesting
cardioprotective ligands to anesthesiologists and clinicians
due to their widely used perioperatively. Schultz’s group
first reported that morphine-induced preconditioning
mimicked ischemic preconditioning [13]. Accumulating
data demonstrated that morphine-induced postcon-
ditioning provided powerful cardioprotective effect,
which seemed to be similar to ischemic postcon-
ditioning [12,14-17]. So far, the vast majority of previous
studies assessed the impact of morphine-induced
postconditioning on cardioprotection in animal experi-
ments. However,there were few reports focused on
morphine-induced postconditioning in the field of
cardiac surgery, especially pediatric cardiac surgery
[12,18]. Although major advances have been made in
the field of cardiac surgery for Tetralogy of Fallot
(TOF), inadequate myocardial protection may remain a
persistent source of mortality and morbidity associated
with surgery for TOF [19]. Whether morphine-induced
postconditioning has an additive effect on cardioplegia
or not in the setting of pediatric cardiac surgery for
TOF remains to be determined.
The purpose of this study was to test the hypothesis
that morphine-induced postconditioning could provide
enhanced cardio-protection against ischemia/ reperfu-
sion injury in children undergoing corrections of TOF.Methods
Subjects
Eligible patients were less than 18 years of age, sched-
uled for total correction of TOF, and cardiac function
NYHA class I-III.
Exclusion criteria were as follows: TOF with pulmonary
atresia, TOF with absent pulmonary artery, concomitant
infective endocarditis, prior palliation with a systemic-to
-pulmonary artery shunt, postoperative residual ventricu-
lar septal defect, and postoperative moderate and severe
pulmonary valve regurgitation.
All selected patients underwent preoperative electro-
cardiogram, chest X-ray film and echocardiography.
None of selected patients received preoperative inotropic
support. The guardians of selected patients signed an in-
formed consent approved by the ethics committee.Grouping
This study protocol was approved by the ethics commit-
tee of Tongji hospital affiliated to Tongji University and
was consistent with the Declaration of Helsinki.
All selected patients were divided randomly into
either a postconditioning group or a control group
through a computer-generated randomization sequence.
The randomization assignment for each patient was
kept in a sealed envelope which was opened by a trial
investigator at the time of patient enrollment. The hos-
pital staff caring for postoperative patients was blinded
for group allocation.
In the postconditioning group, starting at 3 min before
aorta cross-clamp removal, patients received a dose of
morphine (0.1 mg/kg) injected via a cardioplegia needle
into the aortic root for direct and focused delivery to the
heart within 1 minute. In the control group, the same
protocol was performed as in the postconditioning
group except that patients received the same volume of
saline instead.
With reference to previous reports [20,21], in which
0.1 mg/kg was indicated as better dosage for morphine
postconditioning, we used the dosage for morphine
postconditioning in this trial.Clinical data
The pre-, intra- and post-operative relevant data of all
selected patients were investigated and analyzed. Pre-
operative information included age, gender, weight,
McGoon ratio, left ventricular end-diastolic volume
index (LVEDVI), left ventricular ejection fraction (LVEF),
cardiac output, hemoglobin, and saturation of arterial
blood oxygen (in absence of supplemental oxygen ad-
ministration). Intraoperative variables included operative
type (transannular patches or not), duration of cardio-
pulmonary bypass (CPB) and aortic cross clamping
(ACC), and resumption of cardiac activity/rhythm. Post-
operative data included the first postoperative 24-hour
parameters (such as urine volume, drainage volume,
blood transfusion volume, peak inotropic score, creatin-
ine, use of furosemide as well as its intravenous infusion
dose), duration of mechanical ventilation and intensive
care unit (ICU) stay, and in-hospital mortality. Echocar-
diography was performed to assess LVEF and cardiac
output during the first postoperative day and before dis-
charge. All patients were followed up for at least 30 days
following surgery.
The McGoon ratio is calculated by dividing the sum of
the diameter of the bilateral central pulmonary arteries
by the diameter of the descending aorta at the level of
the diaphragm. The first postoperative 24-hour quantita-
tive measures of inotropes were evaluated by the ino-
tropic score according to the following formula [22]:
Zhang et al. Journal of Cardiothoracic Surgery 2013, 8:76 Page 3 of 6
http://www.cardiothoracicsurgery.org/content/8/1/76([dopamine + dobutamine] ×1) + (milrinone × 15) +
([epinephrine + norepinephrine + isoprenaline] ×100).
Management of inotropic dose was according to
hemodynamic stability as reflected by such parameters
as arterial blood pressure, central venous pressure, etc.
Dopamine was employed as the first-line inotrope with
epinephrine and/or norepinephrine as second-line inotrope
for hemodynamic support in cases of hemodynamic in-
stability as reflected by systemic blood pressure inadequacy
despite maximal fluid management and dopamine use.
Weaning from mechanical ventilation depended on
hemodynamics, arterial blood gas analysis, etc. to assess for
cardiopulmonary function; no excessive bleeding and a
mandatory chest radiograph before extubation to rule out
pneumothorax, pleural effusion and atelectasis. Criteria for
leaving ICU included an alert, hemodynamically stable pa-
tient with an inotropic score less than 5, better pulmonary
function with no metabolic acidosis, urine output more
than 0.5 ml/kg/h and a mandatory chest radiograph before
leaving ICU to rule out pneumothorax, pleural effusion
and atelectasis. The indications that guided the use of fur-
osemide included oliguria (urine output <0.5 ml/kg/h) and
development of hypervolemia [8].
Blood sampling and biochemical analysis
For each patient, 2 ml blood samples were collected pre-
operatively, and then 4 hours, 8 hours, 12 hours, 24
hours, and 48 hours after aorta cross-clamp removal for
determination of the plasma levels of cardiac troponin I
(cTnI). The blood samples were transferred into dry
glass tubes and stored at 4°C until centrifugation. Plasma
separated after centrifugation was frozen at −80 C until
assayed for cTnI using the cTnI ELISA kit which was
obtained from Jidan Biotechnology Company (Nanjing,
China). The cTnI values were expressed as ng/ml (nor-
mal reference value in our hospital: <0.15 ng/mL). The
cTnI concentration was measured in the clinical labora-
tory of our hospital by individuals unaware of the group
allocation.
Total cTnI release in the control and postconditioning
group was represented as an area under curve (AUC) from
preoperation (C0) to the last sampling time (C48). It was
calculated using the equation for determining trapezoid
area as follows [8]: AUC0-48 = [(C0+C4) ×4+ (C4+C8) ×4+
(C8+C12) ×4+ (C12+C24) ×12+ (C24+C48) ×24] /2. Total
cTnI release from C0 to C8 and C8 to C48 represented
as AUC0-8 and AUC8-48 respectively, were calculated
accordingly.
Operation
During the surgical procedure, anesthesia was induced
with midazolam (0.05 mg/kg), fentanyl (4 μg/kg) and
vecuronium (0.1 μg/kg), and maintained with intravenous
fentanyl (total amount of fentanyl was less than 15 μg/kgduring operation). All the operations were performed by
the same surgical team. The operations were performed
using moderate hypothermic cardiopulmonary bypass
(28-31°C) with bicaval cannulation and left heart venting
via the right superior pulmonary vein. The myocardium
was protected using intermittent perfusion of cold blood
cardioplegic solution at 4°C and in a ratio of 1:4. The cold
blood cardioplegia which was composed of sodium chlor-
ide at 132 mmol/L, potassium chloride at 16 mmol/L,
calcium chloride at 1.8 mmol/L, magnesium sulphate at
15 mmol/L, procaine at 0.05 mmol/L, and sodium bicar-
bonate at 19 mmol/L, was infused into the aortic root if
there was no aortic valve regurgitation. For patients with
aortic regurgitation, the aorta was opened promptly
after the cross-clamp was applied, the left and right
coronary artery ostia were cannulated, and the cold
blood cardioplegia was delivered though a Y bifurcated
catheter. The initial dose of cardioplegia infused was at
20 ml/kg; thereafter, the cardioplegia solution was re-
infused every 30 min at a dose of 10 ml/kg. Modified
ultrafiltration was used following separation from by-
pass. All patients received similar standard postopera-
tive care in our institution.
Statistical analysis
The sample size calculations are based on a serum con-
centration of cTnI at post-reperfusion time points of 4
hours of 0.60 ng/mL for the postconditioning group and
of 0.75 ng/mL for the control group according to results
of preliminary studies. With an α level of 0.05 and a test
power of 0.80, the resulting sample size was 40 patients
for each group. A risk of loss of patients to follow up of
1-5% was assumed.
Statistical analysis was performed using the SPSS
13.0 statistical software package. Data are expressed as
means ± standard deviation for continuous variables,
and frequencies were measured for categorical variables.
The unpaired t-test or t’-test according to homogeneity
test for variance was used to compare measurement data
and Fisher’s exact test was used to compare enumeration
data. Repeated-measure analysis of variance was used to
evaluate differences over time within groups for cTnI.




From January 2010 to December 2011, after obtained
approval by the ethic committee and written informed
consent, a total of 99 consecutive patients who met the
inclusion criteria were randomly divided either into a
postconditioning group (n=49) or into a control group
(n=50). Among them, 10 patients were excluded (infect-
ive endocarditis in 5 patients, TOF with absent left




Age (years) 4.2±1.8 4.4±1.5 0.5702
Gender (male/female) 26/18 25/20 0.8312
Weight (kg) 13.6±4.5 14.1±4.7 0.6096
McGoon ratio 1.33±0.20 1.38±0.25 0.3010
LVEDVI (ml/m2) 32.8±4.5 33.4±5.3 0.5667
LVEF 0.62±0.17 0.64±0.15 0.5575
Cardiac output (L/min) 0.94±0.21 0.97±0.24 0.5323
Hemoglobin (g/L) 183±34 175±28 0.2285
SaO2 (%) 74±16 78±13 0.1985
LVEDVI, left ventricular end-diastolic volume index; LVEF, left ventricular
ejection fraction; SaO2, saturation of arterial blood oxygen.







Transannular patches (%) 33 (75.0%) 30
(66.7%)
0.4858
CPB time (min) 85±17 83±15 0.5575
Aortic cross-clamp time (min) 61±12 58±12 0.2415
Rhythm recovery
Spontaneous a 40 (90.9%) 36
(80.0%)
0.2297
Defibrillation b 4 (9.1%) 9
(20.0%)
Redo surgery for bleeding 1 (2.3%) 1 (2.2%) 1.0000




Drainage volume (ml/kg/24 h) 17±4 18±5 0.3010
Peak inotropic score 5.7±2.4 8.4±3.6 <0.0001
Urine volume (ml/kg/24 h) 66±14 61±13 0.0843
Creatinine (mg/dl) 0.8±0.3 0.8±0.2 1.0000









Duration of ICU stay (h) 40.4±10.3 57.8
±15.2
<0.0001
Mortality 0 1 (2.2%) 1.0000
a Heart beat restored after aortic cross-clamp removal without electric
defribrillation; b Heart beat restored after aortic cross-clamp removal with one
or more electric defribrillation.
CPB, cardiopulmonary bypass; LVEF, left ventricular ejection fraction; ICU,
intensive care unit.
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sidual VSD in 2 patients). Finally, the outcome analysis
was conducted on 44 patients in the postconditioning
group and 45 patients in the control group.
Clinical outcomes
The preoperative clinical data are shown in Table 1. No
significant differences were noted with regard to age,
gender, weight, McGoon ratio, LVEDVI, LVEF, cardiac out-
put, hemoglobin, and saturation of arterial blood oxygen
between two groups. The operative and postoperative data
are shown in Table 2. Patients from the two groups were
similar with regard to the types of procedure, duration of
bypass as well as aortic clamping, reoperation for bleeding,
and the first postoperative 24-hour urine volume, blood
transfusion volume, drainage volume and serum creatinine
level. The first postoperative 24-hour inotropic drug score
and use of furosemide as well as its intravenous infusion
dose in the postconditioning group was significantly less
than those in the control group (5.7±2.4 versus 8.4±3.6,
p<0.0001; 20.5% versus 42.2%, p=0.0395; 1.2±0.3 versus
1.7±0.4 mg/kg, p=0.0027). Patients received morphine-
induced postconditioning were less likely to present
short duration of mechanical ventilation and ICU stay as
compared to control patients (20.6±6.8 versus 28.5±8.3
hours, p<0.0001 and 40.4±10.3 versus 57.8±15.2 hours,
p<0.0001, respectively). Only one patient in the control
group died of pulmonary infection on the 11th day after
surgery. Pre- and post-operative LVEF and cardiac output
are shown in Table 3. Morphine-induced postconditioned
patients had higher LVEF as well as cardiac output on the
first postoperative day (0.57±0.15 versus 0.51±0.13,
p=0.0467 and 1.39 ± 0.25 versus 1.24 ± 0.21 L/min,
p=0.0029, respectively) as compared to the control group.
Level of plasma cTnI
As shown in Figure 1, serum concentration of cTnI in-
creased sharply after surgery, reaching its peak within 4hours, afterward only to be followed by a slow decline in
both groups (time effect, F=61.45, p=0.000 for the
postconditioning group and F=215.37, p=0.000 for the
control group). Significant differences between the two
groups were found at post-reperfusion time points of 4
hours and 8 hours (0.57 ± 0.15 versus 0.75 ± 0.20 ng/mL,
p<0.0001 and 0.44±0.13 versus 0.50±0.12 ng/mL, p=0.0261,
respectively). The AUC0-48 and AUC0-8 of cTnI release for
the postconditioning group were significantly reduced
as compared to the control group (14.68±3.52 versus
17.31±4.76, p=0.0040 and 3.06±0.93 versus 4.52±1.12,
p<0.0001, respectively), although the AUC8-48 of the
two groups were alike (11.62±2.59 versus 12.79±3.64,
p=0.078).
Discussion
The important finding of this trial was that morphine-
induced postconditioning was related to less cTnI







Baseline data 0.62±0.17 0.64±0.15 0.5575
Postoperative first day 0.57±0.15 0.51±0.13 0.0467
Before discharge 0.63±0.18 0.60±0.16 0.4080
Cardiac output (L/min)
Baseline data 0.94±0.21 0.97±0.24 0.5323
Postoperative first day 1.39±0.25 1.24±0.21 0.0029
Before discharge 1.55±0.31 1.47±0.28 0.2046
Figure 1 Changes in levels of plasma cTnI over time.
(Postconditioning: postconditioning group; Control: control group;
cTnI: cardiac troponin I).
Zhang et al. Journal of Cardiothoracic Surgery 2013, 8:76 Page 5 of 6
http://www.cardiothoracicsurgery.org/content/8/1/76release postoperatively. Results of this trial showed that
levels of plasma cTnI at all time-points after reperfusion
increased sharply and remained high for at least 48
hours in both groups, which meant myocardial injury
occurred and lasted for at least 48 hours after reperfu-
sion. Plasma cTnI levels hit their peak values at the
post-reperfusion time point of 4 hours in both groups,
demonstrating myocardial injury occurred mostly during
the first 4 hours after reperfusion. The morphine-
induced postconditioned patients showing significant re-
duction of cTnI levels at the time points of 4 and 8
hours, especially the AUC calculation over the first 48
hours after aortic cross-clamp removal as compared to
the control patients, might imply that the morphine-
induced postconditioned patients received less myocar-
dium injury as compared to the control patients. So,
morphine-induced postconditioning used in this trial
was able in part to relieve myocardial injury in patients
with TOF undergoing cardioplegic arrest. Since most of
cTnI is eliminated in urine, urine output might signifi-
cantly affect its serum level [8,19]. Consequently, we
concomitantly investigated the patients’ urine output
during their first 24 hours in ICU, and found no signifi-
cant difference in urine output between the two groups.
Therefore, we can infer that the differences in serum
cTnI levels between the two groups, particularly the
cTnI AUC levels, could not be related to urine output
but rather reflected release of different concentrations of
cTnI by the two groups at different time points in this
trial.
Two important mechanisms of cellular damage have
been associated with cardioplegic arrest during open
heart surgery, namely ischemic injury and reperfusion
injury. In this trial, morphine-induced postconditioning
reduced postoperative peak release of cTnI at the post-
reperfusion time point of 4 hours by 31.6% compared to
the control group and total cTnI release by 47.7% during
the first postoperative 8 hours, suggesting that morphine-
induced postconditioning may help to reduce myocardial
injury induced by ischemia. However, cTnI release in thepostconditioning group was similar to the control group
at the post-reperfusion time points of 12, 24 and 48 hours,
and the AUC8-48 of the two groups were alike, which
might indicate that the degree of myocardial injury in-
duced by the reperfusion was similar in the two groups
and that morphine-induced postconditioning had failed to
reduce myocardial injury induced by reperfusion [8,11].
This result was consistent with ischemic postconditioning
reported previously [7,9,19].
Another important finding of this trial was that the
morphine-induced postconditioned patients received some
clinical benefits. Morphine-induced postconditioning re-
duced the peak inotropic score as well as the use of fur-
osemide and increased LVEF as well as cardiac output
during the first postoperative day, which might imply that
morphine-induced postconditioning was related to better
postoperative hemodynamics. In addition, the duration of
mechanical ventilation in the postconditioning group was
much shorter than that in the control group, which might
infer that morphine-induced postconditioning was related
to better postoperative cardiopulmonary function. Less
inotropic drug use, higher LVEF as well as cardiac output,
and shorter duration of mechanical ventilation coincided
with reduction of plasma cTnI release, which might con-
tribute to shorter length of ICU stay in morphine-induced
postconditioned patients undergoing corrections of TOF.
Although its protective effects could not be translated into
more obvious clinical benefits such as lower mortality,
morphine-induced postconditioning really provided en-
hanced cardioprotection and produced some clinical bene-
fits mentioned above.
There are several limitations of this trial. Firstly, some
important clinical decisions (for example, inotropes)
were decided by clinician at work instead of specific pro-
tocols, weakening the inotropic score as an important
endpoint of this trial. Secondly, enrolled patients were in
a low-medium risk condition with short duration of aor-
tic cross-clamping. It remains to be determined if high-
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clamping may benefit more from morphine-induced
postconditioning. Thirdly, fentanyl also is a widely used
opioid along with morphine during general anesthesia,
and fentanil-induced postconditioning also protects is-
chemia/reperfusion. The plasma concentrations of fentanil
were not measured in this study. Finally, this study was
only a clinical observational trial in a single centre. Effect-
ive myocardial tissue concentration of morphine was not
detected in this clinical trial, and the precise mechanisms
of morphine-induced postconditioning in humans were
not explored. Multi-centre clinical trials involving larger
sample size are needed to determine the clinical effect of
morphine-induced postconditioning in pediatric cardiac
surgery.
Conclusions
In summary, this trial showed morphine-induced post-
conditioning before the removal of the aortic clamp was
related to less cTnI release, decreased inotropic drug use,
increased LVEF as well as cardiac output, and shorter dur-
ation of mechanical ventilation as well as ICU stay. This
clinical observational trial suggested morphine-induced
postconditioning may provide enhanced cardioprotection
against ischemia/reperfusion injury in children undergoing
corrections of TOF.
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